Nelson Peltz vs. Disney: Battle for control heats up
Disney's pushback against Nelson Peltz highlights the ongoing tension between outsiders and established leadership.
Staff or Guest writer for The Dog of Wall Street.
2023-01-12 11:27

Disney's (NYSE: DIS) recent pushback against outsider investor Nelson Peltz is a clear indication of the ongoing tension between established leadership and outsiders who want more transparency and accountability. Peltz's desire for internal data and a seat on the board is a clear indication that he does not trust the current leadership and wants to have more control over the company's direction.
Nelson Peltz vs. Disney: Battle for control heats up
One of the key issues that the company is facing is the need to cut costs. Disney's recent $1.45 billion loss in streaming is not sustainable in the long term, and both CEO Bob Iger and Peltz agree that cost-cutting is necessary. However, cutting costs in the creative industry is not a straightforward task, particularly when the company is competing in the streaming wars. Disney will need to navigate this challenge carefully to ensure that they can become more profitable without sacrificing creativity and innovation.

Another concern that is raised by this situation is the lack of confidence in Iger's ability to right the ship and find a successor. Peltz's desire to limit Iger's tenure to two years suggests that he does not believe Iger has the ability to turn things around and that a new leader is needed. This is a significant concern for Disney, as leadership transitions can be difficult and disruptive for a company. It's essential for the board to address this issue and ensure that the company has a clear plan for the future.

Overall, Disney's pushback against Nelson Peltz highlights the ongoing tension between outsiders and established leadership, the importance of cost-cutting, and the need for a clear plan for the future. For shareholders and fans of Disney, I hope that the company will be able to navigate these challenges and continue to provide us with the entertaining and innovative content that we have come to expect.

Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

Published On
2023-01-12 11:27

About the Author
Staff or Guest writer for The Dog of Wall Street.

Analyst Ratings
Target Price$125.93
# of Analysts28
Last updated2022-12-19

You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

AI-mazing returns: The top 3 AI stocks to invest in now!
Don't miss out on the opportunity to invest in these cutting-edge companies and be a part of the future of AI.
By Staff | 2 weeks ago

Goldman Sachs Trims the Fat with 3,200 Job Cuts
Goldman Sachs is cutting approximately 3,200 jobs from its core banking and trading units.
By Staff | 4 weeks ago

Tilray Q2 Earnings Leave Investors Wanting More
While Tilray has maintained its leading market share in the recreational cannabis market in Canada and the medical cannabis market in Europe, its Q2 earnings, which included a loss per share of -$0.11 and an adjusted loss per share of -$0.06, have left investors questioning the company's future growth prospects.
By Staff | 4 weeks ago

Qualcomm's partnership with Iridium takes connectivity to new heights
Qualcomm's partnership with Iridium brings satellite-based messaging technology to phones, laptops and other devices, providing new opportunities for connectivity in any location.
By Staff | 4 weeks ago

Hologic's Fiscal Q1 2023 Earnings: A Ray of Hope in a Stormy Year
Hologic has managed to achieve impressive financial results in Fiscal Q1 2023.
By Staff | 4 weeks ago

Why Small and Mid-Cap Stocks Deserve Your Attention
Why valuations make small and mid-cap stocks an attractive option in a potential recession.
By Staff | 4 weeks ago

Get Ready for a Bumpy Year
Despite strong job creation numbers, deeper issues lurk beneath the surface as the Federal Reserve's rate hikes and high inflation threaten to derail the economy.
By Staff | 4 weeks ago